Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FJUVK
- Awardee
-
Dakota Drug, Inc. UEI H544BCGUKW64
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,022
Award facts
- Contract value 100% obligated
- $14,022.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Anoka, MN, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $14,022.32 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder. This firm fixed-price delivery order, awarded on July 18, 2025, with completion targeted for July 21, 2025, represents a continuation of Dakota Drug's role as a critical pharmaceutical supplier to the U.S. military healthcare system. The award carries no set-aside designation and is issued under Dakota Drug's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 31, 2025, which falls under the ECAT Generation V Program and originates from solicitation SPE2DH-21-R-0002.
Dakota Drug, Inc. has established itself as a key vendor for medical procurement across the federal marketplace, with particular strength in supplying respiratory medications, diabetes management products, pain management pharmaceuticals, and other critical medications to military medical facilities. Trelegy Ellipta is a combination inhaler used for chronic obstructive pulmonary disease management, aligning with the company's demonstrated capability to deliver respiratory medications to defense healthcare operations. The delivery order reflects the ongoing demand for commercial pharmaceutical products to support U.S. Armed Forces medical operations through DLA's supply chain.
Quick answers
Who was awarded contract SPE2DB25FJUVK?
SPE2DB25FJUVK was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FJUVK worth?
The government has obligated $14,022 on SPE2DB25FJUVK.
Is contract SPE2DB25FJUVK an order under another contract?
Yes. SPE2DB25FJUVK is a delivery order under SPE2DB24D8003, an indefinite delivery contract.
Was contract SPE2DB25FJUVK competed?
The extent of competition for SPE2DB25FJUVK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award